Higher serum total bilirubin predicts high risk of 3-year adverse outcomes in patients undergoing primary percutaneous coronary intervention

References

• Mahabadi AA, Lehmann N, Mohlenkamp S, et al. Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study. Clin Res Cardiol. 2014;103(8):647–653. doi:10.1007/s00392-014-0697-z24633678
   PubMed Web of Science ®Google Scholar
• Chung SR, Yang TH, Shin HC, et al. Initial total bilirubin and clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents. Circ J. 2016;80(6):1437–1444. doi:10.1253/circj.CJ-15-139727151334
   PubMed Web of Science ®Google Scholar
• Ajja R, Lee DC, Sui X, Church TS, Steven NB. Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men. Am J Cardiol. 2011;108(10):1438–1442. doi:10.1016/j.amjcard.2011.06.06721864819
   PubMed Web of Science ®Google Scholar
• Nishimura T, Tanaka M, Saisho Y, Miyakoshi K, Tanaka M, Itoh H. Lower serum total bilirubin concentration is associated with higher prevalence of gestational diabetes mellitus in Japanese pregnant women. Endocr J. 2018;65(12):1199–1208. doi:10.1507/endocrj.EJ17-053330305483
   PubMed Web of Science ®Google Scholar
• Chin HJ, Song YR, Kim HS, et al. The bilirubin level is negatively correlated with the incidence of hypertension in normotensive Korean population. J Korean Med Sci. 2009;24:S50–S56. doi:10.3346/jkms.2009.24.S1.S5019194562
   PubMed Web of Science ®Google Scholar
• Han SS, Na KY, Chae DW, Kim YS, Kim S, Chin HJ. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohoku J Exp Med. 2010;221(2):133–140.20495302
   PubMed Web of Science ®Google Scholar
• Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arter Thromb Vasc Biol. 1996;16(2):250–255. doi:10.1161/01.ATV.16.2.250
   PubMed Web of Science ®Google Scholar
• Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary-artery disease. Clin Chem. 1994;40(1):18–23.8287538
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Bakker SJ, Gansevoort RT, Chowdhury R, Dullaart RP. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol. 2015;35(3):716–724. doi:10.1161/ATVBAHA.114.30492925593130
   PubMed Web of Science ®Google Scholar
• Kim HW, Choi DH, Lim L, et al. Usefulness of serum bilirubin levels as a biomarker for long-term clinical outcomes after percutaneous coronary intervention. Heart Vessels. 2015;30(6):728–733. doi:10.1007/s00380-014-0546-z25048679
   PubMed Web of Science ®Google Scholar
• Zhang MM, Gao Y, Zheng YY, et al. Association of fasting serum bilirubin levels with clinical outcomes after percutaneous coronary intervention: a prospective study. Cardiovasc Toxicol. 2017;17(4):471–477. doi:10.1007/s12012-017-9405-328283905
   PubMed Web of Science ®Google Scholar
• Wei S, Mao L, Liu B, Zhong L. Serum biomarkers and the prognosis of AMI patients. Herz. 2014;39(3):384–389. doi:10.1007/s00059-013-3828-923649322
   PubMed Web of Science ®Google Scholar
• Huang SS, Huang PH, Leu HB, Wu T-C, Lin S-J, Chen J-W. Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X. Heart. 2010;96(15):1227–1232. doi:10.1136/hrt.2009.19239320639239
   PubMed Web of Science ®Google Scholar
• McCallum L, Panniyammakal J, Hastie CE, et al. Longitudinal blood pressure control, long-term mortality, and predictive utility of serum liver enzymes and bilirubin in hypertensive patients. Hypertension. 2015;66(1):37–43. doi:10.1161/HYPERTENSIONAHA.114.0491525941342
   PubMed Web of Science ®Google Scholar
• Yao HM, Shen DL, Zhao XY, et al. Prognostic value of total bilirubin in patients with angina pectoris undergoing percutaneous coronary intervention. Int J Clin Exp Med. 2015;8(9):15930–15939.26629096
   PubMed Web of Science ®Google Scholar
• Acet H, Erts F, Akil MA, et al. A novel predictor of infarct-related artery patency before percutaneous intervention and in-hospital outcomes for ST-segment elevation myocardial infarction patients: serum bilirubin level. Postep Kardiol Inter. 2014;10(2):91–97. doi:10.5114/pwki.2014.43513
   PubMed Web of Science ®Google Scholar
• Celik T, Kaya MG, Akpek M, et al. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI. Angiology. 2014;65(3):198–204. doi:10.1177/000331971247494823378197
   PubMed Web of Science ®Google Scholar
• Gul M, Uyarel H, Ergelen M, et al. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2013;111(2):166–171. doi:10.1016/j.amjcard.2012.09.01123102877
   PubMed Web of Science ®Google Scholar
• Huseynov A, Baumann S, Becher T, et al. Liver and cholestatic parameters as prognostic biomarkers of in-hospital MACE in patients with STEMI. Eur J Clin Invest. 2016;46(8):721–729. doi:10.1111/eci.1265527369447
   PubMed Web of Science ®Google Scholar
• Wu AH, Levy WC, Welch KB, et al. Association between bilirubin and mode of death in severe systolic heart failure. Am J Cardiol. 2013;111(8):1192–1197. doi:10.1016/j.amjcard.2012.12.04823351460
   PubMed Web of Science ®Google Scholar
• Frikha Z, Ferreira JP, Bozec E, et al. Relation of high serum bilirubin to short-term mortality following a myocardial infarction complicated by left ventricular systolic dysfunction (from the high-risk myocardial infarction database initiative). Am J Cardiol. 2018;121(9):1015–1020. doi:10.1016/j.amjcard.2018.01.01229631805
   PubMed Web of Science ®Google Scholar
• Yao HM, Wan YD, Zhang XJ, et al. Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre. BMJ Open. 2014;4(8):e004892. doi:10.1136/bmjopen-2014-004892
   PubMed Web of Science ®Google Scholar
• Yao H, Wan Y, Zhang X, et al. Data from: long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI center. Dryad Digital Repository. 2014. doi:10.5061/dryad.13d31
   Google Scholar
• Breimer LH, Mikhailidis DP. Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target? Curr Pharm Des. 2011;17(33):3644–3655.22074434
   PubMed Web of Science ®Google Scholar
• Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke. 2009;40(11):3422–3427. doi:10.1161/STROKEAHA.109.56064919713538
   PubMed Web of Science ®Google Scholar
• Amor AJ, Ortega E, Perea V, et al. Relationship between total serum bilirubin levels and carotid and femoral atherosclerosis in familial dyslipidemia. Arter Thromb Vasc Biol. 2017;37(12):2356–2363. doi:10.1161/ATVBAHA.117.310071
   PubMed Web of Science ®Google Scholar
• Shen H, Zeng C, Wu X, Liu S, Chen X. Prognostic value of total bilirubin in patients with acute myocardial infarction: A meta-analysis. Medicine (Baltimore). 2019;98(3):e13920. doi:10.1097/MD.000000000001392030653097
   PubMed Web of Science ®Google Scholar
• Sahin O, Akpek M, Elcik D, et al. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI. Angiology. 2013;64(3):200–204. doi:10.1177/000331971244061922492252
   PubMed Web of Science ®Google Scholar
• Htun NM, Chen YC, Lim B, et al. Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques. Nat Commun. 2017;8(1):75. doi:10.1038/s41467-017-00138-x28706202
   PubMed Web of Science ®Google Scholar
• Mito S, Ozono R, Oshima T, et al. Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1. Hypertension. 2008;51(6):1570–1577. doi:10.1161/HYPERTENSIONAHA.107.10256618426999
   PubMed Web of Science ®Google Scholar
• Okuhara K, Kisaka T, Ozono R, et al. Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation. South Med J. 2010;103(9):876–881. doi:10.1097/SMJ.0b013e3181eac06a20689484
   PubMed Web of Science ®Google Scholar
• Amanvermez R, Acar E, Gunay M, Baydın A, Yardan T, Bek Y. Hsp 70, hsCRP and oxidative stress in patients with acute coronary syndromes. Bosn J of Basic Med Sci. 2012;12(2):102–107. doi:10.17305/bjbms.2012.250822642594
   PubMed Web of Science ®Google Scholar